Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Critical Care
•
ARDS
Do you use spO2 to define ARDS in patients with darker skin pigmentation?
Related Questions
Do you continue to prone patients with severe ARDS after initiation of VV-ECMO?
Do you consider use of convalescent plasma early in disease course in COVID-19 induced ARDS in mechanically ventilated patients?
Can intra-abdominal pressure serve as a surrogate for pleural pressure to titrate PEEP in obese patients or those with intra-abdominal hypertension?
How do you manage acute hypernatremia from diabetes insipidus in patients with pre-existing cerebral edema?
What factors do you consider for patients on an individual basis when establishing a post-cardiac arrest MAP goal after ROSC is achieved, considering some may benefit from higher MAP goals for optimal cerebral perfusion?
In patients being evaluated for brain death, which abnormal movements are definitively known to still be consistent with brain death and which are possibly consistent with brain death but lack definitive evidence?
What is the upper limit of blood glucose target in hyperglycemic critically ill patients?
Is the adage “If GCS <8, intubate” still relevant for non-TBI patients?
Do you administer prophylactic antibiotics to prevent VAP following intubation in patients with acute brain injury?
What strategies do you use to prevent overcorrection of serum sodium in patients with severe hyponatremia and adrenal insufficiency when initiating glucocorticoid therapy?
